High voltage with anniversary campaign for BB Biotech
"What's next?" This question is the focus of the campaign for the 30th anniversary of BB Biotech, an investment company that has invested in Moderna, among others. The campaign was commissioned to the agency Hochspannung.
For the 30th anniversary of the investment company BB Biotech, the Zurich agency Hochspannung developed a campaign that asks: "What's next? A question that the responsible analysts, scientists and financial experts have been asking and answering again and again for 30 years.
Over the past decades, for example, BB Biotech has invested in numerous companies, including Actelion, Genentech and Moderna, which gained notoriety two years ago with the development of a Covid vaccine. The question of the next big trend in the development of new medicine also drives those responsible at BB Biotech with regard to future developments. And so the question "What's next?" is still anchored in the DNA of the investment company today as it has been for the past three decades.
The only thing that has changed markedly since the beginnings in 1993 is the way information is obtained, which is skilfully reflected in the visual implementation of the campaign. The campaign is based on digital media, print and posters and will run until the end of the year.
Responsible at Hochspannung Werbeagentur Zurich: Alexander Taiganidis, Matthew Katumba, Fritz Kreis, Tanja Kongolo, Monika Jagodzinski, Johannes Jordan, Sophie Graf, Nyima Weber.
